These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12902353)

  • 1. Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion.
    Rhie A; Kirby L; Sayer N; Wellesley R; Disterer P; Sylvester I; Gill A; Hope J; James W; Tahiri-Alaoui A
    J Biol Chem; 2003 Oct; 278(41):39697-705. PubMed ID: 12902353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative computational analysis of prion proteins reveals two fragments with unusual structural properties and a pattern of increase in hydrophobicity associated with disease-promoting mutations.
    Kuznetsov IB; Rackovsky S
    Protein Sci; 2004 Dec; 13(12):3230-44. PubMed ID: 15557265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
    Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA molecules stimulate prion protein conversion.
    Deleault NR; Lucassen RW; Supattapone S
    Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras.
    Kupfer L; Eiden M; Buschmann A; Groschup MH
    Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of conformationally selective, prion-binding aptamers.
    Sayer NM; Cubin M; Rhie A; Bullock M; Tahiri-Alaoui A; James W
    J Biol Chem; 2004 Mar; 279(13):13102-9. PubMed ID: 14711834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites.
    King DJ; Safar JG; Legname G; Prusiner SB
    J Mol Biol; 2007 Jun; 369(4):1001-14. PubMed ID: 17481659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.
    Elmallah MI; Borgmeyer U; Betzel C; Redecke L
    Prion; 2013; 7(5):404-11. PubMed ID: 24121542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions.
    Béland M; Roucou X
    J Neurochem; 2012 Mar; 120(6):853-68. PubMed ID: 22145935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamers against prion proteins and prions.
    Gilch S; Schätzl HM
    Cell Mol Life Sci; 2009 Aug; 66(15):2445-55. PubMed ID: 19396399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian prions: tolerance to sequence changes-how far?
    Salamat MK; Munoz-Montesino C; Moudjou M; Rezaei H; Laude H; Béringue V; Dron M
    Prion; 2013; 7(2):131-5. PubMed ID: 23232499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
    Faburay B; Tark D; Kanthasamy AG; Richt JA
    Prion; 2014; 8(6):393-403. PubMed ID: 25495764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA aptamers specifically interact with the prion protein PrP.
    Weiss S; Proske D; Neumann M; Groschup MH; Kretzschmar HA; Famulok M; Winnacker EL
    J Virol; 1997 Nov; 71(11):8790-7. PubMed ID: 9343239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.